Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miki Ohira

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Cancer Science|August 25, 2010
Global genomic and RNA profiles for novel risk stratification of neuroblastomaMiki Ohira, Akira Nakagawara
Cancer Letters|March 12, 2004
Comprehensive genomics linking between neural development and cancer: neuroblastoma as a modelAkira Nakagawara, Miki Ohira
BMC Genomics|December 26, 2022
Comparative epigenomics by machine learning approach for neuroblastomaRyuichi P Sugino, Miki Ohira, Sayaka P Mansai, et al.
International Journal of Oncology|May 13, 2004
Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomasShiho Hamano, Miki Ohira, Eriko Isogai, et al.
Cancer Informatics|September 1, 2009
Robust model selection for classification of microarraysIkumi Suzuki, Takashi Takenouchi, Miki Ohira, et al.
European Journal of Cell Biology|May 31, 2022
The PRC2 molecule EED is a target of epigenetic therapy for neuroblastomaDilibaerguli Shaliman, Hisanori Takenobu, Ryuichi P Sugino, et al.
Journal of Human Genetics|July 22, 2016
Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypesSasagu Kurozumi, Yuri Yamaguchi, Masafumi Kurosumi, et al.
Cancer Science|April 2, 2015
Correlation between the International Neuroblastoma Pathology Classification and genomic signature in neuroblastomaAtsuko Nakazawa, Chizuko Haga, Miki Ohira, et al.
Gynecologic Oncology|December 13, 2016
Identification of novel mutations in Japanese ovarian clear cell carcinoma patients using optimized targeted NGS for clinical diagnosisYoshiaki Maru, Naotake Tanaka, Miki Ohira, et al.
Biochemical and Biophysical Research Communications|February 6, 2007
Functional characterization of a new p53 mutant generated by homozygous deletion in a neuroblastoma cell lineYohko Nakamura, Toshinori Ozaki, Hidetaka Niizuma, et al.
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Cancer Science|August 25, 2010
Global genomic and RNA profiles for novel risk stratification of neuroblastomaMiki Ohira, Akira Nakagawara
Cancer Letters|March 12, 2004
Comprehensive genomics linking between neural development and cancer: neuroblastoma as a modelAkira Nakagawara, Miki Ohira
BMC Genomics|December 26, 2022
Comparative epigenomics by machine learning approach for neuroblastomaRyuichi P Sugino, Miki Ohira, Sayaka P Mansai, et al.
International Journal of Oncology|May 13, 2004
Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomasShiho Hamano, Miki Ohira, Eriko Isogai, et al.
Cancer Informatics|September 1, 2009
Robust model selection for classification of microarraysIkumi Suzuki, Takashi Takenouchi, Miki Ohira, et al.
European Journal of Cell Biology|May 31, 2022
The PRC2 molecule EED is a target of epigenetic therapy for neuroblastomaDilibaerguli Shaliman, Hisanori Takenobu, Ryuichi P Sugino, et al.
Journal of Human Genetics|July 22, 2016
Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypesSasagu Kurozumi, Yuri Yamaguchi, Masafumi Kurosumi, et al.
Cancer Science|April 2, 2015
Correlation between the International Neuroblastoma Pathology Classification and genomic signature in neuroblastomaAtsuko Nakazawa, Chizuko Haga, Miki Ohira, et al.
Gynecologic Oncology|December 13, 2016
Identification of novel mutations in Japanese ovarian clear cell carcinoma patients using optimized targeted NGS for clinical diagnosisYoshiaki Maru, Naotake Tanaka, Miki Ohira, et al.
Biochemical and Biophysical Research Communications|February 6, 2007
Functional characterization of a new p53 mutant generated by homozygous deletion in a neuroblastoma cell lineYohko Nakamura, Toshinori Ozaki, Hidetaka Niizuma, et al.
Pageof 10